References
  1. Bagshaw SM, Hoste EA, Jacka MJ. Best evidence in critical care medicine. Intensive vs conventional blood glucose control in critically ill patients. Can J Anaesth. 2010; 57: 172-5.
  2. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001; 345: 1359-67.
  3. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000; 355: 773-8.
  4. Bistrian BR. Hyperglycemia and infection: which is the chicken and which is the egg? JPEN J Parenter Enteral Nutr. 2001; 25: 180-1.
  5. Coşkun R, Gündoğan K, Güven M, Sungur M. Efficacy of an insulin infusion treatment protocol administered in a medical intensive care unit.  J Crit Intensive Care. 2012; 1: 9-12.
  6. Qaseem A, Chou R, Humphrey LL, Shekelle P, Clinical Guidelines Committee of the AmericaN College of P. Inpatient glycemic control: best practice advice from the Clinical Guidelines Committee of the American College of Physicians. Am J Med Qual. 2014; 29(2): 95-8.
  7. American Diabetes Associadion. Diabetes care in the hospital: standards of medical care in diabetes-2019. Diabetes Care. 2019; 42(Suppl 1): 173-81.
  8. Bilotta F, Badenes R, Lolli S, Belda FJ, Einav S, Rosa G. Insulin infusion therapy in critical care patients: regular insulin vs short-acting insulin. A prospective, crossover, randomized, multicenter blind study. J Crit Care . 2015; 30(2):437.e1-6.
  9. Doglietto GB, Bellantone R, Bossola M, Perri V, Ratto C, Pacelli F, Crucitti F. Insulin adsorption to three‐liter ethylen vinyl acetate bags during 24‐hour infusion. JPEN J Parenter Enteral Nutr.  1989; 13(5): 539-41.
  10. Jakobsson T, Shulman R, Gill H, Taylor K. The impact of insulin adsorption onto the infusion sets in the adult intensive care unit. J Diabetes Sci Technol.  2009; 3(1): 213-4.
  11. Ng KX, Yeo JHT, Woo FZ, Wong JPY, Sethi SK, Loh TP. Insulin adsorption by infusion sets in the setting of treatment of hyperkalaemia. Wien Klin Wochenschr. 2016; 128(11-12): 460-1.
  12. Peterson L, Caldwell J, Hoffman J. Insulin adsorbance to polyvinylchloride surfaces with implications for constant-infusion therapy. Diabetes. 1976; 25(1): 72-4.
  13. Petty C, Cunningham NL. Insulin adsorption by glass infusion bottles, polyvinylchloride infusion containers, and intravenous tubing. Anesthesiology. 1974; 0(4): 400-4.
  14. Thompson CD, Vital-Carona J, Faustino EVS. The effect of tubing dwell time on insulin adsorption during intravenous insulin infusions. Diabetes Technol Ther.  2012; 4(10): 912-6.
  15. Trissel LA, Xu QA, Baker M. Drug compatibility with new polyolefin infusion solution containers. Am J Health Syst Pharm.  2006; 63(23), 2379-82.
  16. Zahid N, Taylor KM, Gill H, Maguire F, Shulman R. Adsorption of insulin onto infusion sets used in adult intensive care unit and neonatal care settings. Diabetes Res Clin Pract 2008; 80(3): e11-e13.
  17. Goldberg PA, Kedves A, Walter K, Groszmann A, Belous A, Inzucchi SE. ”Waste Not, Want Not”: Determining the Optimal Priming Volume for Intravenous Insulin Infusions. Diabetes Technol Ther.  2006; 8(5): 598-601.
  18. Kalra S, Bajwa SJ. Intravenous insulin use: technical aspects and caveats. JPMA.  2013; 63(5): 650-3.
  19. Turner RE. Insulin administration for the control of blood glucose in the adult ICU-an evidence-based guideline: guideline. SAJCC.  2007; 23(1): 24-30.
  20. Turkish Pharmacopoeia. Turkish Medicines and Medical Devices Agency; Place, 2017.
  21. Guideline IHT. (2005). Validation of analytical procedures: text and methodology. Q2 (R1). 2005; 1: 1-15.
  22. Fuloria M, Friedberg MA, DuRant RH, Aschner JL. Effect of flow rate and insulin priming on the recovery of insulin from microbore infusion tubing. Pediatrics. 1998; 102(6): 1401–6.